Revelation Biosciences Inc (NASDAQ:REVB)’s traded shares stood at 1.64 million during the last session, with the company’s beta value hitting -0.32. At the close of trading, the stock’s price was $3.20, to imply a decrease of -13.28% or -$0.49 in intraday trading. The REVB share’s 52-week high remains $60.80, putting it -1800.0% down since that peak but still an impressive 26.25% since price per share fell to its 52-week low of $2.36. The company has a valuation of $2.90M, with an average of 0.22 million shares in intraday trading volume over the past 10 days and average of 130.01K shares over the past 3 months.

Analysts have given a consensus recommendation of Buy for Revelation Biosciences Inc (REVB), translating to a mean rating of 1.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give REVB a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy.

Revelation Biosciences Inc (NASDAQ:REVB) trade information

After registering a -13.28% downside in the last session, Revelation Biosciences Inc (REVB) has traded red over the past five days. The 5-day price performance for the stock is 19.85%, and -4.19% over 30 days. With these gigs, the year-to-date price performance is -56.62%. Short interest in Revelation Biosciences Inc (NASDAQ:REVB) saw shorts transact 23472.0 shares and set a 0.36 days time to cover.

REVB Dividends

Revelation Biosciences Inc has its next earnings report out on 2025-Mar-05. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

Revelation Biosciences Inc (NASDAQ:REVB)’s Major holders

Revelation Biosciences Inc insiders hold 5.09% of total outstanding shares, with institutional holders owning 6.81% of the shares at 7.17% float percentage. In total, 6.81% institutions holds shares in the company.

We also have Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund as the top two Mutual Funds with the largest holdings of the Revelation Biosciences Inc (REVB) shares. Going by data provided on Feb 28, 2025 , Fidelity Concord Street Trust-Fidelity Extended Market Index Fund holds roughly 501.0 shares. This is just over 0.06% of the total shares, with a market valuation of $1603.0. Data from the same date shows that the other fund manager holds a little less at 363.0, or 0.04% of the shares, all valued at about 1161.0.